These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 29488676
1. Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. Cosmi F, Shen L, Magnoli M, Abraham WT, Anand IS, Cleland JG, Cohn JN, Cosmi D, De Berardis G, Dickstein K, Franzosi MG, Gullestad L, Jhund PS, Kjekshus J, Køber L, Lepore V, Lucisano G, Maggioni AP, Masson S, McMurray JJV, Nicolucci A, Petrarolo V, Robusto F, Staszewsky L, Tavazzi L, Teli R, Tognoni G, Wikstrand J, Latini R. Eur J Heart Fail; 2018 May; 20(5):888-895. PubMed ID: 29488676 [Abstract] [Full Text] [Related]
2. Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. Shen L, Rørth R, Cosmi D, Kristensen SL, Petrie MC, Cosmi F, Latini R, Køber L, Anand IS, Carson PE, Granger CB, Komajda M, McKelvie RS, Solomon SD, Staszewsky L, Swedberg K, Huynh T, Zile MR, Jhund PS, McMurray JJV. Eur J Heart Fail; 2019 Aug; 21(8):974-984. PubMed ID: 31271255 [Abstract] [Full Text] [Related]
3. Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study. Kim YG, Yoon D, Park S, Han SJ, Kim DJ, Lee KW, Park RW, Kim HJ. Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28899989 [Abstract] [Full Text] [Related]
4. Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure. Rørth R, Fosbøl EL, Mogensen UM, Kragholm K, Numé AK, Gislason GH, Jhund PS, Petrie MC, McMurray JJV, Torp-Pedersen C, Køber L, Kristensen SL. Eur J Heart Fail; 2018 Feb; 20(2):240-247. PubMed ID: 29148231 [Abstract] [Full Text] [Related]
5. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification. Lawson CA, Jones PW, Teece L, Dunbar SB, Seferovic PM, Khunti K, Mamas M, Kadam UT. JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131 [Abstract] [Full Text] [Related]
6. Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients. Stubnova V, Os I, Grundtvig M, Waldum-Grevbo B. Cardiology; 2016 Jan; 134(4):413-22. PubMed ID: 27120050 [Abstract] [Full Text] [Related]
11. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care. Hippisley-Cox J, Coupland C. BMJ; 2016 Jul 12; 354():i3477. PubMed ID: 27413012 [Abstract] [Full Text] [Related]
12. Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study. Kuo S, Yang CT, Wu JS, Ou HT. Diabetes Obes Metab; 2019 Feb 12; 21(2):312-320. PubMed ID: 30187666 [Abstract] [Full Text] [Related]
14. Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database. Fadini GP, Avogaro A, Degli Esposti L, Russo P, Saragoni S, Buda S, Rosano G, Pecorelli S, Pani L, OsMed Health-DB Network. Eur Heart J; 2015 Sep 21; 36(36):2454-62. PubMed ID: 26112890 [Abstract] [Full Text] [Related]
17. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry. Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM, Drozdz J, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro MG, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L, ESC-HFA HF Long-Term Registry investigators. Eur J Heart Fail; 2017 Jan 21; 19(1):54-65. PubMed ID: 27790816 [Abstract] [Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure. Ou SM, Chen HT, Kuo SC, Chen TJ, Shih CJ, Chen YT. Heart; 2017 Mar 21; 103(6):414-420. PubMed ID: 27647170 [Abstract] [Full Text] [Related]
19. Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry. Targher G, Dauriz M, Tavazzi L, Temporelli PL, Lucci D, Urso R, Lecchi G, Bellanti G, Merlo M, Rossi A, Maggioni AP, IN-HF Outcome Investigators. Int J Cardiol; 2016 Jan 15; 203():587-93. PubMed ID: 26574932 [Abstract] [Full Text] [Related]
20. Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus. Jang SY, Jang J, Yang DH, Cho HJ, Lim S, Jeon ES, Lee SE, Kim JJ, Kang SM, Baek SH, Cho MC, Choi DJ, Yoo BS, Kim KH, Park SK, Lee HY. Cardiovasc Diabetol; 2021 Sep 08; 20(1):180. PubMed ID: 34496864 [Abstract] [Full Text] [Related] Page: [Next] [New Search]